37
▪ History of bleeding coagulopathies or use of anticoagulants except for
low-dose aspirin.
▪ Patients with history of diseases stimulated by heat, such as recurrent
Herpes Simplex in the treatment area, may be treated only following a
prophylactic regimen.
▪ Impaired immune system due to immunosuppressive diseases such as
AIDS and HIV or use of immunosuppressive medications.
▪ Pregnancy and nursing.
▪ Poorly controlled endocrine disorders, such as Diabetes, or thyroid
dysfunction and hormonal virilization.
▪ Isotretinoin (Accutane) within last 6 months.
▪ Any active condition in the treatment area, such as sores, Psoriasis,
eczema, and rash, open lacerations, abrasions or lesions, infection in
the area to be treated.
▪ Any surgical procedure in the treatment area within the last 12 months
or before complete healing.
▪ Having received treatment with light, laser, RF, or other devices in the
treated area within 2-3 weeks for non-ablative procedures, and 6-12
weeks for ablative fractional laser resurfacing (according to treatment
severity) prior to treatment, except special recommendations.
▪ Use of non-steroidal anti-inflammatory drugs (NSAIDS, e.g., ibuprofen-
containing agents) one week before and after each treatment session,
as per the practitioner’s discretion.
▪ Application of the device near the thorax may increase risk of cardiac
fibrillation
▪ Avoid application of device over the head, eyes, across the mouth and
front of neck
▪ As per the practitioner's discretion, refrain from treating any condition
which might make it unsafe for the patient.
7.3 Precautions
▪ Safety of powered muscle stimulators for use during pregnancy has not
been established.
▪ Caution should be used for patients with suspected or diagnosed heart
problems.
To Next Page
Loading...
